Research
Research grants
Immunological stratification of Head and neck squamous cell carcinomas to guide treatment choices with immunotherapy (Akoya)
THE CLATTERBRIDGE CANCER CENTRE NHS FOUNDATION TRUST (UK)
May 2023 - May 2024
LAG-3 expression in solid tumours
BRISTOL-MYERS SQUIBB PHARMACEUTICALS LTD (UK)
March 2022 - September 2022
Epigenomic and Transcriptomic Profile of Human Immune Cells
NATIONAL INSTITUTES OF HEALTH (USA)
August 2021 - July 2024
Respiratory pathogen-specific T cell signatures following vaccinationt, natural infection, and treatment
NATIONAL INSTITUTES OF HEALTH (USA)
June 2022 - May 2027
Understanding recognition of tumour antigens by T-cells in NSCLC for cancer vaccine development
NORTH WEST CANCER RESEARCH INCORPORATING CLATTERBRIDGE CANCER RESEARCH (UK)
April 2024 - March 2026
AST-VAC sequencing project
CANCER RESEARCH UK (UK)
November 2023 - September 2024
Akoya Biosciences Phenocycler Fusion
THE CLATTERBRIDGE CANCER CHARITY (UK)
October 2022 - October 2023
Functional and dysfunctional human CD4 T cell and B cell responses to bacteria and viruses
NATIONAL INSTITUTES OF HEALTH (USA)
March 2023 - February 2024
The tumour microenvironment and the effect that various treatments and vaccines have on the immune cells within the tumour
SOUTHAMPTON HOSPITALS CHARITY (UK), THE CLATTERBRIDGE CANCER CHARITY (UK)
October 2021 - October 2028
LHNC Stage 2: consolidation for clinical impact
NORTH WEST CANCER RESEARCH INCORPORATING CLATTERBRIDGE CANCER RESEARCH (UK)
November 2023 - March 2028
Targeting non-small cell lung cancer with personalised doggybone DNA vaccines (db-PCV) (NEOVACC)
MEDICAL RESEARCH COUNCIL
December 2023 - November 2027
PROTIS: A phase III trial of proton beam therapy versus intensity-modulated radiotherapy for the treatment of sinonasal malignancy (PROTIS)
CANCER RESEARCH UK (UK)
March 2022 - March 2031
Liverpool ECMC (LECMC)
CANCER RESEARCH UK (UK)
April 2023 - March 2028